LifeSpan Vision Ventures has made a significant investment in Remedium Bio, a biotechnology firm renowned for its groundbreaking gene therapy platform, Prometheus™. This latest funding is set to propel Remedium Bio’s innovative approach to gene therapy into new realms of clinical research and application. Remedium Bio is at the forefront of biotechnology with its Prometheus™…
Congruex, a leading provider of comprehensive digital network services, has appointed Shane Portfolio as its new Chief Technology Officer. With an illustrious career marked by transformative leadership in digital network engineering, Portfolio joins Congruex to spearhead technological innovation and extend nationwide connectivity solutions. Shane Portfolio brings nearly three decades of profound industry experience, cultivated during…
Verituity, a leader in intelligent payout solutions, has successfully closed an $18.8 million funding round led by Sandbox Industries and Forgepoint Capital, with participation from Ardent Venture Partners and MTech Capital. This funding infusion is set to propel Verituity’s growth across banking, insurance, mortgage servicing, and energy sectors, marking a significant stride in its mission…
In a groundbreaking move aimed at enhancing healthcare accessibility for underserved communities, Alchemy has successfully closed a $31 million seed financing round. The funding, led by Andreessen Horowitz (“a16z”) Bio + Health, garnered support from notable investors, including NBA legend Earvin “Magic” Johnson, Sandberg Bernthal Venture Partners, Banc of California, and existing backers such as…
In a pivotal move set to redefine hospitality standards worldwide, Valpas, the pioneering provider of tech-driven bedbug prevention solutions, has announced a triumphant €4 million seed funding round. Spearheaded by Zenith VC and joined by a consortium of leading investors including Icebreaker VC and Finnish Industry Investment, this funding marks a significant milestone for Valpas…
In a decisive move to globalize its leadership and ambitions, South Korean aesthetics major Hugel Inc. has appointed Carrie Strom, a seasoned US pharmaceutical executive, as its President and Global Chief Executive Officer, effective immediately. This marks the creation of a newly formed global CEO position at Hugel—one that signals a shift from domestic dominance…
Prominent venture capital firm Headline has successfully raised $865 million for its latest fund, Headline Global Growth IV. This fund focuses on investing in technology companies at pivotal growth stages, specifically from Series B and beyond. With this substantial capital commitment, Headline aims to bolster its support for tech founders and accelerate their journey toward…
Pearl Health, a pioneering force in democratizing healthcare access through innovative software and services, celebrates CEO and co-founder Michael Kopko’s recognition as an EY Entrepreneur Of The Year® 2024 New York Award winner. Ernst & Young LLP (EY US) bestowed this prestigious accolade upon Kopko in acknowledgment of his transformative leadership and Pearl Health’s impactful…
Saronic, a leader in autonomous surface vessel (ASV) technology, has secured a massive $175 million Series B funding round, propelling the company to a coveted unicorn status with a valuation of $1 billion. This investment, led by Andreessen Horowitz (a16z), will fuel Saronic’s mission to revolutionize naval warfare with its next-generation unmanned technology. Saronic’s ASVs,…
Beacon Therapeutics, a pioneering ophthalmic gene therapy company dedicated to combating blinding retinal diseases, has secured $170 million in Series B funding, marking a significant stride towards advancing its transformative treatments. Led by Forbion and supported by existing investors Syncona and Oxford Science Enterprises, alongside newcomers TCGX and Advent Life Sciences, this funding round will…
